Skip to main content

Table 2 Baseline clinical, angiographic and procedural characteristics of propensity-matched patients with and without diabetes stratified according to medical therapy or successful CTO-PCI

From: Long-term outcomes of medical therapy versus successful recanalisation for coronary chronic total occlusions in patients with and without type 2 diabetes mellitus

 

Propensity-matched patients with diabetes

Propensity-matched patients without diabetes

Medical therapy

Successful PCI

P value

Medical therapy

Successful PCI

P value

(n = 270)

(n = 135)

(n = 464)

(n = 232)

Age, years

65.2 ± 4.7

64.6 ± 9.1

0.648

63.7 ± 10.9

63.2 ± 9.9

0.340

Male

187 (69.3)

100 (74.1)

0.315

372 (80.5)

184 (79.7)

0.787

Smoking

102 (37.8)

55 (40.7)

0.564

65 (14.1)

26 (11.3)

0.301

Hypertension

197 (73.0)

96 (71.1)

0.694

302 (65.4)

151 (65.4)

1.000

Insulin-dependent DM

106 (39.3)

50 (37.0)

0.665

–

–

–

Dyslipidemia

213 (78.9)

102 (75.6)

0.447

330 (71.4)

162 (70.1)

0.722

Familial history o CAD

23 (8.5)

12 (8.9)

0.900

118 (25.5)

56 (24.2)

0.710

Previous MI

115 (42.6)

59 (43.7)

0.831

79 (17.1)

40 (17.3)

0.943

CKD

33 (12.2)

15 (11.1)

0.744

37 (8.0)

15 (6.5)

0.475

Heart failure

60 (22.2)

30 (22.2)

1.000

57 (12.3)

21 (9.1)

0.202

LVEF, %

52.1 ± 10.9

52.4 ± 9.8

0.764

54.0 ± 8.3

54.9 ± 7.6

0.876

Baseline medication

 Aspirin

265 (98.1)

132 (97.8)

0.801

451 (97.6)

224 (97.0)

0.612

 Clopidogrel

256 (94.8)

128 (94.8)

1.000

442 (95.7)

227 (98.3)

0.078

 Statin

256 (94.8)

131 (97.0)

0.306

441 (95.5)

221 (95.7)

0.897

 β blocker

196 (72.6)

103 (76.3)

0.424

369 (79.9)

188 (81.4)

0.636

 ACEI or ARB

172 (63.7)

85 (63.0)

0.884

289 (62.6)

142 (61.5)

0.782

 One CTO lesion

235 (87.0)

115 (85.2)

0.608

392 (84.8)

192 (83.1)

0.555

 Two CTO lesions

33 (12.2)

19 (14.1)

0.599

63 (13.6)

35 (15.2)

0.589

 LAD

85 (31.5)

51 (37.8)

0.206

175 (37.9)

89 (38.5)

0.868

 LCX

73 (27.0)

38 (28.1)

0.813

120 (26.0)

62 (26.8)

0.807

 RCA

143 (53.0)

62 (45.9)

0.182

232 (50.2)

113 (48.9)

0.747

 Multivessel disease

221 (81.9)

105 (77.8)

0.329

360 (77.9)

154 (66.7)

0.001

 Proximal or mid

170 (63.0)

94 (69.6)

0.184

341 (73.8)

170 (73.6)

0.159

CTO location

 Blunt stump

85 (31.5)

33 (24.4)

0.142

183 (39.6)

74 (32.0)

0.052

 Calcification

32 (11.9)

17 (12.6)

0.829

71 (15.4)

38 (16.5)

0.712

 Bending > 45°

117 (43.3)

58 (43.0)

0.943

206 (44.6)

86 (37.2)

0.064

 Length ≥ 20 mm

160 (59.3)

85 (63.0)

0.472

306 (66.2)

141 (61.0)

0.178

 J-CTO score

1.43 ± 1.16

1.41 ± 0.98

0.216

1.63 ± 1.11

1.44 ± 1.05

0.139

 SYNTAX score

23.7 ± 8.3

22.4 ± 7.9

0.658

24.2 ± 8.5

22.7 ± 7.8

0.504

  1. Values are presented as the mean ± standard deviation or n (%)
  2. ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin-receptor blocker, CAD coronary artery disease, CKD chronic kidney disease, CTO chronic total occlusion, J-CTO Japanese-chronic total occlusion, LAD left ascending coronary artery, LCX left circumflex coronary artery, LVEF left ventricular ejection fraction, MI myocardial infarction, PCI percutaneous coronary intervention, RCA right coronary artery